key: cord-0459667-yatopg4n authors: Duran, Nelson; Favaro, Wagner J. title: Pyroptosis: Physiological roles in viral infection date: 2020-06-29 journal: nan DOI: nan sha: 230dc9a183f0fb2e5a278cdfea896b711c18d1a7 doc_id: 459667 cord_uid: yatopg4n The current review focuses on important aspects of pyroptosis, such as morphological features of inflammasomes, as well as on knowledge about coronavirus infection mechanisms and the association between SARS-CoV-2 infection and cell pyroptosis. The application of immunomodulation therapies to Covid-19 patients is the most promising treatment under investigation nowadays. The possibilities of assistance to help protecting patients from infections are also addressed in the present study. • Inflammatory caspases play an important role in innate immunity. • Pyroptosis eliminates the reproduction site of intracellular pathogens. • SARS-CoV proteins triggers NLRP3 inflammasome induction. • SARS-CoV-2 infection and cell pyroptosis. • Immunomodulation therapies to Covid-19 patients is the most promising treatment. It is well known that inflammatory caspases play an important role in innate immunity by responding to cytosolic signals and by inducing a twofold response (Jorgensen and Miao, 2015) . First, caspase-1 induces the activation and release of pro-inflammatory cytokines, such as interleukin-18 (IL-18) and IL-1β. Second, caspase-11 or caspase-1 can trigger a lytic, programmed cell death known as pyroptosis. Pyroptosis eliminates the reproduction site of intracellular pathogens, such as bacteria or virus, which makes them susceptible to phagocytosis and to be destroyed by secondary phagocytes. However, anomalous systemic activation of pyroptosis in vivo may lead to sepsis in some cases. Several pathogens have evolved to prevent or disrupt pyroptosis, a fact that highlights inflammasomes' ability to recognize viral infections. These effects are also observed in many health conditions (Ma et al., 2018; Liang et al., 2020) such as cardiovascular diseases (Zeng et al., 2019) and cancer (Durán and Fávaro, 2020; unpublished results). It is known that respiratory epithelial cell (REC) death caused by influenza virus infection is responsible for triggering immune response to inflammation; however, the exact cell death mechanisms triggered in these cases remain poorly understood. Data available in the literature have indicated that apoptosis is triggered at initial infection stages although the cell death route is displaced to pyroptosis at late infection stages. It was suggested that the change from apoptosis to pyroptosis is stimulated by the type I interferon (I-IFN)-mediated JAK-STAT signaling pathway, which inhibits apoptosis through the expression of the Bcl-xL anti-apoptotic gene. Moreover, JAK-STAT signaling suppression has inhibited pyroptosis and increased apoptosis in infected AAH (human atypical adenomatous hyperplasia) and PL16T (respiratory epithelial cells). Accordingly, Lee et al. (2018) have suggested that the type I interferon (I-IFN) signaling route activates pyroptosis, rather than apoptosis, in RECs in a reciprocally exclusive mode and triggers pro-inflammatory response to influenza virus infection (Lee et al., 2018) . The important role played by inflammatory response induction has been emphasized by several studies, so far. The inflammasome detection system is capable of identifying a large array of pathogen-connected molecular patterns, and it indicates that inflammatory caspases play a key role in protecting hosts from any type of pathogen (Man et al., 2017) . For instance, DNA and RNA viruses can activate inflammasomes and trigger pyroptosis (Lupfer and Kanneganti, 2013; Man et al., 2016) . However, studies have highlighted the harmful role played by pyroptosis in patients with HIV infection (Jakobsen et al., 2013; Monroe et al. 2014; Doitsh et al., 2014; Galloway et al., 2015; Munõz-Arias et al., 2015) . Non-infected liver cells can also suffer caspase-1-dependent pyroptosis after witness cell infection with HCV (hepatitis C virus) (Kofahi et al., 2016 (Thomas et al., 2012; Allen et al., 2009; Ichinohe et al., 2009) , decreased IL-1β, IL-18, TNF, IL-6, KC, MIP-2 in the BALF, decreased neutrophils and monocytic dendritic cells in the BALF, diminished respiratory function (Thomas et al., 2009) , decreased IFNγ producing CD4+ and CD8+ T cells, reduced nasal IgA, increased pulmonary viral titer (Ichinohe et al., 2009) . No difference in survival and body weight change in Mx1 sufficient host (Pillai et al., 2016) Murine gamma-herpesvirus 68 (MHV68) No difference in viral burden in the lungs (Cieniewicz et al., 2015) . No difference in survival (Rajan et al., 2011) . Reduced survival (Ramos et al., 2012) . Zhao and Zhao (2020) can also impair NLRP3 inflammasome activation through different mechanisms. Protein degradation and NLRP3 ubiquitination is the regulatory mechanism solution for NLRP3 inflammasome induction. Several viral proteins can moderate NLRP3 degradation and inhibit NLRP3 inflammasome induction. These degradation processes can affect GSDMD and this anomalously breakage GSDMD derivative fails to activate infected-cell pyroptosis, which triggers viral replication and leads to viral escape. This interchange is partly indicative of the complex virus/host co-evolution and may enable potential treatments in the near future (Zhao and Zhao, 2020) Besides microbial infections, type I interferon (I-IFN) signaling contributes to cell decease caused by IAV. Type I-IFN signaling affects the positive regulation of ZBP1 innate immune sensor (known as DLM-1 or DAI (DNA-dependent activator of IFN-regulatory factors) (Kuriakose et al., 2016) . ZBP1 recognizes the IAV nucleoprotein and the PB1 subunit of RNA polymerase; besides, it influences the activation of NLRP3 inflammasome, apoptosis and necroptosis through caspase-8, kinase RIPK3 and FADD (FAS-associated protein with death domain) (Kuriakose et al., 2016) . These data were corroborated by other studies Nogusa et al., 2016) , which highlighted the role played by the type I-IFN/ZBP1 axis in IV-induced cell death (Man et al., 2017a) . Some mechanistic aspects of pyroptosis in viruses were reported; for instance, IAV induces NLRP3 inflammasome (Kanneganti et al., 2006; Thomas et al., 2009; Allen et al., 2009; Kuriakose et al., 2016) . Casp1 −/−Casp11 −/− mice are more susceptible to IAV infection than wild-type mice (Thomas et al., 2009; Allen et al., 2009; Ichinohe et al., 2009) . They generate lesser IL-18 and IL-1β in the lungs, which reduce lung functions and increases viral titers (Thomas et al., 2009; Ichinohe et al., 2009) Although several studies focused on investigating the function of caspase-1 and caspase-11 has been conducted, their action in vivo remains poorly understood. IAVs and pathogens other than Gram-negative bacteria do not transport lipopolysaccharide (LPS), which is the PAMP inducing caspase-11. However, it is possible assuming that caspase-11 has the function of protecting hosts from microbial agents other than Gramnegative bacteria in vivo. The function of both caspase-1 and caspase-11 has been seen in host protection from Aspergillus fumigatus (fungal pathogen), which is a pathogen that does not transport LPS (Karki et al., 2015; Man et al., 2017b; ) . A. fumigatus induces NLRP3 inflammasome in THP-1 cells (human leukemia monocytic cell line), as well as AIM2 (absent in melanoma 2) and NLRP3 inflammasomes in mouse dendritic cells from bone-marrow and lung tissue (Saud-Sadier et al., 2010; Karki et al., 2015) . Caspase-1-dependent response triggered the production of defensive cytokines IL-18 and IL-1β in a murine model of Aspergillosis (Karki etr al., 2015) . Most importantly, Caspase-11 −/− mice are also highly sensitive to A. fumigatus-induced lethality in comparison to wild-type mice; however, collapse to infection with a late kinetics as compared with mice with the absence of caspase-1 or both caspase-11 and caspase-1 (Man et al., 2017a) . The caspase-11 activation or defense mechanism during A. fumigatus infections remains poorly understood. Caspase-11 activation might induce killing through actin-mediated phagosomal in order to control A. fumigatus propagation in vivo (Akhter et al., 2012; Caution et al., 2015; Walle et al., 2016) . Caspase-1-dependent liberates IL-18 generates IFN-γ, which may supply a briefing signal for caspase-11 to regulate Aspergillosis in vivo (Karki et al., 2015) . A study has suggested that, besides LPS, caspase-11 is capable of identifying oxidized phospholipids in hosts by means of an associated molecular pattern that triggers IL-1β release in dendritic cells without causing pyroptosis (Zanoni et al. 2016 ). However, most recently, a study reported that caspase-1 and caspase-11 have triggered Most recently, a study conducted with models such as cell lines, microbial strains, mice and human liver biopsy tissues, has found that pyroptosis effector protein gasdermin D (GSDMD) was broken by inflammasome-induced caspase-1 and LPS-activated caspase-11/4/5 . The fragmentation revealed domain where the pore were formed at gasdermin D-C terminal domain (GSDMD-C). Besides, the specific caspase-4/11 autoprocessing site, which produces the p10 product, played an essential role in breaking GSDMD and in causing pyroptosis. The p10 product effectively binds to the GSDMD-C domain. The comparison between auto-processed and non-processed capase-11 structures has identified a β-sheet generated by auto-processing. The β-sheet assembles a hydrophobic binding GSDMD interface in the crystal structure of GSDMD-C/caspase-4/11 complex; that was only likely for p10 product from the complex. The crystalline arrangement of GSDMD-C/caspase-1 complex has shown similar GSDMDidentification mode . As previously mentioned, unlike apoptosis, pyroptosis comprises inflammation, the activation of a variety of caspases, mainly the caspase-1, which incises and polymerizes Gasdermin family members like GSDMD . The N-terminal cleavage product of GSDMD can cause extensive cell perforation by penetrating the lipid bilayer to induce high-order oligomerization in the membrane (Huang et al., 2017) . This process is followed by cellular content release, which causes inflammation, cell swelling and lysis to prevent invading pathogens from replicating (Liu et al., 2016; Shi et al., 2017; Zhang et al., 2018) . Once the cell is damaged (chemicals, disease-induced), several intracellular molecules with immunomodulatory activity are released from immune cells (Pandolfi et al., 2016) . These molecules are called DAMPs, also known as alarm factor (Alcano et al., 2019). Similar to the aforementioned PAMPs, DAMPs can also be recognized by NLRP3 and lead to similar effects, such as pro-inflammatory responses and pyroptosis, as previously described (Ma et al., 2018; Gao et al., 2018) . Pyroptosis progresses faster than apoptosis and it is followed by the release of significant quantities of pro-inflammatory factors. Thus, unlike apoptosis, which is a neat, orderly-shrinking cell phagocytosis process, cell pyroptosis happens faster and triggers inflammation (Yang, 2020) . It is known that once pathogens penetrate the cell, PAMPs are identified by PRRs, such as NLRP3, on the cell membrane and then bind to the precursor of caspase-1(procaspase-1) through the apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) in the cell in order to form a multiprotein complex, thus activating caspase-1 (He et al., 2016; Wang et al., 2019; Yang, 2020) . precursor of caspase-1 through the adaptor protein ASC in order to form a multiprotein complex and activate caspase-1 . On the one hand, caspase1 incises gasdermin D to forms a peptide containing gasdermin D nitrogen-terminal active domain and causes extensive cell perforation by penetrating the lipid bilayer; this process also leads to cell rupture, cellular content release and triggers inflammatory reaction (Shi et al., 2017; Man et al., 2017) . On the other hand, activated caspase-1 incises IL-1β and the precursor of IL-18 to form active IL-18 and IL-1β, which are released within the extracellular region in order to recruit inflammatory cells and spread the inflammatory reaction (Yang, 2020) . As it is known, 2019-nCoV virus was officially called SARS-CoV-2 and the disease was named COVID-19. A study review conducted by Yang et al. (2020) has summarized SARS history and epidemiology. Besides, other authors have pointed out several aspects, such as epidemiology, clinical features, pathogenesis, diagnosis and guidance of patients contaminated with SARS-CoV-2. Epithelial and dendritic cells are activated at initial coronavirus contamination stages and form a cluster of pro-inflammatory cytokines and chemokines such as interleukins (IL-2, IL-6, IL-8, IL-1β), tumor necrosis factor (TNF), interferons (IFN-α/β), C-C motif chemokines and IP-10, among others. All these factors are regulated by the immune system. Therefore, excessive production of all these cytokines and chemokines enable the progress of the disease. Interleukin IL-10, which is generated by T-helper-2 (Th2), has antiviral activity; however, coronavirus infection can significantly inhibit it (Zhang et al., 2020a) (Fig.2) . Based on evidence available in the literature, patients contaminated with SARS-CoV-2 presented increased IL-1β (serum) secretion , which is a strong indicator of cell pyroptosis; it indicates that cell pyroptotic induction may be implicated in the pathogenesis of SARS-CoV-2-infected patients. Although both non-classical and classical pyroptosis signaling are capable of activating IL-1β secretion, this process should be further investigated in SARS-CoV-2 pneumonia patients. Moreover, although both leucopenia and lymphopenia were observed in pneumonia patients, a larger number of SARS-CoV-2 contaminated patients had lymphopenia, which may indicate that lymphocytes are more likely to undergo cell pyroptosis during infection processes. Chen et al. (2020a) observed the same behavior in 99 SARS-CoV-2-pneumonia patients assessed in their study. Almost all patients who died had lymphopenia. Other studies have also observed this finding in a significant number of patients, as follows: 138 hospitalized patients ; 1,099 patients (Guan et al., 2020) ; 140 patients (Zhang et al., 2020b) ; 62 patients (Xu et al., 2020) ; 12 patients ; 34 children (Wang et al., 2020b) ; 29 patients (Chen et al., 2020b) ; 138 patients (Wang et al., 2020c) ; 183 patients (Tang et al., 2020); 5,700 patients (Richarson et al., 2020) ; 21 patients (Arentz et al., 2020) ; and 9 pregnant women (Chen et al, 2020c) . Interestingly, Chang et al. (2020) reported 13 patients with lymphopenia; all patients have recovered and presented marginally high levels of inflammatory markers, such as the number of lymphocytes. All these findings were corroborated by Lipi and Plebani (2020) and by Henry et al (2020) . It is known that either classical or non-classical pyroptosis can trigger IL-1β release, although the exact way it happens in patients with COVID-19 remains unknown. However, based on data available in the literature, SARS-CoV-2 likely causes cell pyroptosis, mainly in lymphocytes, due to NLRP3 inflammasome induction. Then, some aspects still are necessary to study in this area, such as morphological changes of leucocytes and lymphocytes and classical and non-classical cell pyroptosis basic markers on biomolecules (nucleic acid, proteins). Although, in order to a rapid identification of SARS-CoV-2 cell pyroptosis in patients sample a rapid data such as NLRP3, IL-1beta, IL-18, and GSDMD are requested (Fig. 3 ) (Yan, 2020; Yang et al., 2000) . It is known that extensive cytokine release due to immune system reaction to viral contaminations can lead to cytokine storm and sepsis, which account for approximately All studies about Covid-19 and, mainly, all aspects associated with pyroptosis point towards the need of conducting further studies focused on investigating morphological changes taking place in lymphocytes and leucocytes, as well as the expression of classical and non-classical cell pyroptosis markers at both nucleic acid and protein levels. It is important screening cell pyroptosis data such as NLRP3, IL-1beta, IL-18 and GSDMD in samples collected from SARS-CoV-2-pneumonia patients. Actually, very few reports on Covid-19 patients' follow-up address immunological aspects. The patient monitoring process is just based on the characterization of clinical aspects. However, this process must comprise the analysis of immunological data to help better understanding how this virus can be eliminated. The application of immunomodulation therapies to Covid-19 patients is the most promising treatment under investigation nowadays (Ingraham et al., 2020; Delafiori et al., 2020) . Caspase-11 promotes the fusion of phagosomes harboring pathogenic bacteria with lysosomes by modulating actin polymerization Role of damage-associated molecular patterns and uncontrolled inflammation in pediatric sepsis-induced multiple organ dysfunction syndrome The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State Clinical Analysis of 25 Novel coronavirus infections in children Murine Gamma herpes virus 68 pathogenesis is independent of Caspase-1 and Caspase-11 in mice and impairs interleukin-1beta production upon extrinsic stimulation in culture Caspase-11 and caspase-1 differentially modulate actin polymerization via RhoA and Slingshot proteins to promote bacterial clearance Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China Severe Acute respiratory syndrome Coronavirus Viroporin 3a activates the NLRP3 inflammasome Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records RNA viruses promote activation of the NLRP3 inflammasome through cytopathogenic effect-induced potassium efflux A 78-Year Old Urothelial Cancer Patient with Faster Recovery from COVID-19: Potential Benefit from Adjuvant Active Immunotherapy Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection Cell-to cell transmission of HIV-1 is required to trigger pyroptotic death of lymphoid-tissue derived CD4 T cells Recent advances in the molecular mechanisms underlying pyroptosis in sepsis Clinical characteristics of coronavirus disease 2019 in China Mechanism and regulation of NLRP3 inflammasome activation Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): A meta-analysis Clinical features of patients infected with 2019 novel coronavirus in Wuhan Inflammasome recognition of influenza virus is essential for adaptive immune responses Immunomodulation in COVID-19 IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication Complement receptor C5aR1 inhibition reduces pyroptosis in hDPP4-transgenic mice infected with MERS-CoV Pyroptotic cell death defends against intracellular pathogens Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and doublestranded RNA Concerted activation of the AIM2 and NLRP3 inflammasomes orchestrates host protection against Aspergillus infection Hepatitis C virus infection of cultured human hepatoma cells causes apoptosis and pyroptosis in both infected and bystander cells ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways Structure insight of GSDMD reveals the basis of GSDMD autoinhibition in cell pyroptosis Influenza A virus infection triggers pyroptosis and apoptosis of respiratory epithelial cells through the type I interferon signaling pathway in a mutually exclusive manner The advances in pyroptosis initiated by infammasome in infammatory and immune diseases Laboratory abnormalities in patients with COVID-2019 infection Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury The expanding role of NLRs in antiviral immunity Research progress of the relationship between pyroptosis and disease Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases Differential roles of caspase-1 and caspase-11 in infection and inflammation AIM2 inflammasome in infection, cancer, and autoimmunity: Role in DNA sensing, inflammation, and innate immunity IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV Derived CD4 T cells naturally resist pyroptosis during abortive HIV-1 infection RIPK3 activates parallel pathways of MLKL-driven necroptosis and FADD-mediated apoptosis to protect against influenza a virus Key role of DAMP in inflammation, cancer, and tissue repair Mx1 reveals innate pathways to antiviral resistance and lethal influenza disease The NLRP3 inflammasome detects encephalomyocarditis virus and vesicular stomatitis virus infection IL-1beta signaling promotes CNSintrinsic immune control of West Nile virus infection Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area Pyroptosis: Gasdermin-mediated programmed necrotic cell death Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia The trinity of COVID-19: immunity, inflammation and intervention DAI senses influenza a virus genomic RNA and activates RIPK3-dependent cell death The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1 The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease Structural mechanism for GSDMD targeting by autoprocessed caspases in pyroptosis Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series Cell Pyroptosis, a potential pathogenic mechanism of 2019-nCoV infection The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells Role of pyroptosis in cardiovascular diseases and its therapeutic implications. Inter Plasma membrane changes during programmed cell deaths COVID-19: Melatonin as a potential adjuvant treatment Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan NLRP3 Inflammasome-A Key Player in antiviral responses The authors would like to thank the São Paulo Research Council (FAPESP grant 2014/11154-1; 2018/10052-1), and the Brazilian National Council for Scientific and Technological Development (CNPq grant 552120/2011-1) Brazil. https://ssrn.com/abstract=3527420).